Skip to content
LexBuild

Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

---
identifier: "/us/fr/2012-27541"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)"
title_number: 0
title_name: "Federal Register"
section_number: "2012-27541"
section_name: "Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)"
positive_law: false
currency: "2012-11-13"
last_updated: "2012-11-13"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-27541"
document_type: "notice"
publication_date: "2012-11-13"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "77 FR 67651"
fr_volume: 77
---

#  Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

*Time and Date:* 8:00 a.m.-2:45 p.m., December 5, 2012.

*Place:* CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30333.

*Status:* The meeting is open to the public, limited only by the space available.

*Purpose:* The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers.

*Matters To Be Discussed:* The meeting will include reports from the BSC OID working groups, brief updates on activities of the infectious disease national centers, and a discussion on ways to strengthen the clinical and public health interface, with focus on addressing pertussis and implementing new recommendations for reducing hepatitis C virus morbidity and mortality.

Agenda items are subject to change as priorities dictate.

*CONTACT PERSON FOR MORE INFORMATION:*

Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: November 5, 2012.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.